ALX Oncology Holdings Inc. (ALXO) Tops Q4 EPS by 12c

ALX Oncology Holdings Inc. (NASDAQ: ALXO) reported Q4 EPS of ($0.55), $0.12 better than the analyst estimate of ($0.67).

For earnings history and earnings-related data on ALX Oncology Holdings Inc. (ALXO) click here.

You May Also Be Interested In

• loanDepot receives NYSE non-compliance notice over stock price
• OBOOK Holdings posts $18.8M net loss as OwlPay Harbor volume rises
• Real and RE/MAX Holdings receive court approval for merger